Health System Partnerships

About OpenEvidence OpenEvidence is the most widely used clinical decision support platform among U.S. clinicians. According to independent studies, more American physicians use OpenEvidence than all other AI platforms combined, and it is used daily, on average, by 70% of U.S. clinicians to make high-stakes decisions at the point of care, grounded in and cited to peer-reviewed medical literature. We've built that reach with a team of fewer than 90 people, and the company is now valued at $15B, backed by Sequoia, GV, Kleiner Perkins, and Thrive Capital. Our enterprise partnerships with over…